U01DA036939 (Q29051): Difference between revisions

@@ Property / instance of @@
+grant
@@ Property / instance of: grant / rank @@
+Normal rank
@@ Property / instance of: grant / reference @@
+stated in: PubMed
@@ Property / grant identifier @@
+U01 DA036939
@@ Property / grant identifier: U01 DA036939 / rank @@
+Normal rank
@@ Property / grant identifier: U01 DA036939 / reference @@
+stated in: PubMed
@@ Property / NIH funding mechanism @@
+U series
@@ Property / NIH funding mechanism: U series / rank @@
+Normal rank
@@ Property / NIH funding mechanism: U series / reference @@
+stated in: PubMed
@@ Property / award type @@
+U01
@@ Property / award type: U01 / rank @@
+Normal rank
@@ Property / award type: U01 / reference @@
+stated in: PubMed
@@ Property / institute code @@
+DA
@@ Property / institute code: DA / rank @@
+Normal rank
@@ Property / institute code: DA / reference @@
+stated in: PubMed
@@ Property / serial number @@
@@ Property / serial number: 036939 / rank @@
+Normal rank
@@ Property / serial number: 036939 / reference @@
+stated in: PubMed
@@ Property / funder @@
+National Institute on Drug Abuse
@@ Property / funder: National Institute on Drug Abuse / rank @@
+Normal rank
@@ Property / funder: National Institute on Drug Abuse / reference @@
+stated in: PubMed
@@ Property / primary funding institute or center @@
+National Institute on Drug Abuse
+Normal rank
+stated in: PubMed
@@ Property / country of origin @@
+United States of America
@@ Property / country of origin: United States of America / rank @@
+Normal rank
@@ Property / country of origin: United States of America / reference @@
+stated in: PubMed

U01DA036939 (Q29051): Difference between revisions

Latest revision as of 16:36, 6 November 2024

Statements

Navigation menu

Search